Reed Weighs in on Patents, Licenses and Litigation Related to CRISPR
At the 2019 annual meeting of AUTM, a nonprofit with more than 3,000 members who work in more than 800 universities, research centers, hospitals, businesses and government organizations, partner Janet Reed participated in a panel titled “The CRISPR Battlefield: Patents, Licenses and Litigation.”
The panelists analyzed the complex patent landscape surrounding CRISPR, a breakthrough gene-editing technology. They discussed the major patents and challenges they’re facing, various licensing issues, co-existing with universities holding similar technologies, and active litigation associated with CRISPR.
Reed is the head of Potter Anderson’s intellectual property transactional and counseling practice. She has extensive experience in domestic and foreign patent prosecution, patent portfolio management and strategic planning, evaluation of new technology, drafting of license and other commercialization agreements, conducting and responding to due diligence inquiries, and preparation of opinions on patentability, infringement and freedom to operate. In addition to her law degree, Reed holds a Ph.D. in biochemistry and a Master’s degree in plant pathology. Prior to entering patent law, she accumulated 10 years of laboratory experience in biochemistry, molecular biology and plant physiology/pathology, in graduate-level research and as a visiting postdoctoral research scientist at DuPont.
For more information about AUTM’s annual meeting in Austin, Texas, visit the event website.